Biotech | May 26, 2026
Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision
AAV vectors are widely used in gene therapy for their strong therapeutic potential
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
The platform offers personalised recovery plans, AI-driven movement tracking, and access to certified physiotherapists for more than 250 conditions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
